Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 4.96M PLN in the quarter ending June 30, 2026, a decrease of -76.80%. This brings the company's revenue in the last twelve months to 22.11M, down -75.30% year-over-year. In the year 2025, Ryvu Therapeutics had annual revenue of 87.73M, down -14.03%.

• Revenue (ttm): 22.11M
• Revenue Growth: -75.30%
• P/S Ratio: 4.39
• Revenue / Employee: 368.15K
• Employees: 228
• Market Cap: 368.07M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.73M	-14.31M	-14.03%
Dec 31, 2024	102.05M	34.05M	50.08%
Dec 31, 2023	67.99M	-2.50M	-3.54%
Dec 31, 2022	70.49M	34.36M	95.08%
Dec 31, 2021	36.13M	-1.19M	-3.20%
Dec 31, 2020	37.33M	3.19M	9.34%
Dec 31, 2019	34.14M	-71.73M	-67.75%
Dec 31, 2017	105.87M	39.15M	58.68%
Dec 31, 2016	66.72M	10.64M	18.98%
Dec 31, 2015	56.08M	14.52M	34.94%
Dec 31, 2014	41.56M	19.64M	89.63%
Dec 31, 2013	21.91M	-	-

Data Source: Fiscal.ai Last updated: Sep 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error